Reduced expression of FOXE1 in differentiated thyroid cancer, the contribution of CPG methylation, and their clinical relevance.
De Lima EU, Dos Santos FF, Da Silva IC, De Lima CRA, Frutuoso VS, Caso GF, De Oliveira PR, Bezerra AK, Cerutti JM, Tamura RE, Ramos HE, de Rubio IGS.
De Lima EU, et al. Among authors: de lima cra.
Front Endocrinol (Lausanne). 2024 Nov 11;15:1454349. doi: 10.3389/fendo.2024.1454349. eCollection 2024.
Front Endocrinol (Lausanne). 2024.
PMID: 39588344
Free PMC article.